CHI3L1 and lung carcinoma: Although CHI3L1 is a useful biomarker, it is necessary to use multiple biomarkers as a panel for more accurate prediction and verification of lung cancer, as increase of CHI3L1 expression has been shown in other inflammation-related mouse models [14], [15], [16], [17], [18].